Drug reference
evocalcet
Calcium-sensing receptor mimetic · Calcimimetic
Calcium-sensing receptor mimeticCalcimimetic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
secondary hyperparathyroidism in adults with chronic kidney disease (CKD) on dialysis
Contraindications
- initial serum calcium <8.4 mg/dL
Side effects
Serious
- severe hypocalcemia
Related guidelines
Chronic kidney disease — assessment and management
KDIGO · Nephrology · 2024
Acute kidney injury
KDIGO · Nephrology · 2012
Chronic kidney disease — assessment and management
NICE · Nephrology · 2021
Chronic kidney disease — mineral and bone disorder
KDIGO · Nephrology · 2017
Dialysis — initiation and maintenance
ISN_INDIA · Nephrology · 2023
Ask House about evocalcet
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10